PREFERENCES FOR ATTRIBUTES OF ORAL ANTIPSYCHOTIC TREATMENTS: SURVEY RESULTS OF PATIENTS LIVING WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER

被引：0
|
作者：
Doane, M. [1 ]
Boeri, M. [2 ]
Panchmatia, H. [1 ]
Citrome, L. [3 ]
Sajatovic, M. [4 ]
机构：
[1] Alkermes Inc, Waltham, MA USA
[2] RTI Hlth Solut, Belfast, Antrim, North Ireland
[3] New York Med Coll, Valhalla, NY 10595 USA
[4] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR46
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [1] Preferences for characteristics of oral antipsychotic treatments: Survey results of patients living with bipolar I disorder
    Doane, Michael J.
    Boeri, Marco
    Vass, Caroline
    Bussberg, Cooper
    Panchmatia, Hemangi R.
    Gasper, Sabina
    Citrome, Leslie
    Sajatovic, Martha
    BIPOLAR DISORDERS, 2023, 25 : 102 - 102
  • [2] Preferences for attributes of oral antipsychotic treatments: results from a discrete-choice experiment in respondents with schizophrenia or bipolar I disorder
    Doane, Michael J.
    Boeri, Marco
    Vass, Caroline
    Bussberg, Cooper
    Panchmatia, Hemangi R.
    Citrome, Leslie
    Sajatovic, Martha
    BMC PSYCHIATRY, 2024, 24 (01)
  • [3] Psychiatrist and Psychiatric Pharmacists Beliefs and Preferences for Atypical Antipsychotic Treatments in Patients With Schizophrenia and Bipolar Disorders
    Touchette, Daniel R.
    Gor, Deval
    Sharma, Dolly
    Chennault, Rachel R.
    Ng-Mak, Daisy S.
    Rajagopalan, Krithika
    Ellingrod, Vicki
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (01) : 78 - 88
  • [4] Asenapine: A Novel Atypical Antipsychotic Agent for Schizophrenia and Bipolar I Disorder
    Timpe, Erin M.
    Chopra, Ritika A.
    JOURNAL OF PHARMACY TECHNOLOGY, 2010, 26 (06) : 352 - 361
  • [5] Comparative Risk of Oral Ulcerations among Antipsychotic Users with Schizophrenia or Bipolar Disorder
    Lai, Edward Chia-Cheng
    Hsieh, Cheng-Yang
    Setoguchi, Soko
    Yang, Yea-Huei Kao
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 441 - 442
  • [6] Efficacy and tolerability of depot antipsychotic use in patients with schizophrenia and bipolar disorder
    Inanc, Leman
    Ozdemir, Aysun Demir
    Gulec, Huseyin
    Semiz, Umit Basar
    CUKUROVA MEDICAL JOURNAL, 2018, 43 : 38 - 43
  • [7] Adherence to antipsychotic medication in bipolar disorder and schizophrenia patients: a systematic review
    Garcia Fernandez, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S434 - S434
  • [8] Impact of Antipsychotic Treatment Switching in Patients With Schizophrenia, Bipolar Disorder, And Major Depressive Disorder
    Carroll, Benjamin
    Ayyagari, Rajeev
    Thomason, Darren
    Mu, Fan
    Philbin, Michael
    NEUROLOGY, 2019, 92 (15)
  • [9] Amygdala volume in patients with bipolar I disorder or schizophrenia
    Scherk, H.
    Schneider-Axmann, T.
    Usher, J.
    Falkai, P.
    Reith, W.
    Menzel, P.
    Gruber, O.
    BIPOLAR DISORDERS, 2007, 9 : 94 - 95
  • [10] Hospitalization risk factors in antipsychotic-treated schizophrenia, bipolar I disorder or major depressive disorder
    Yan, Tingjian
    Greene, Mallik
    Chang, Eunice
    Broder, Michael S.
    Touya, Maelys
    Munday, Jennifer
    Hartry, Ann
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (04) : 217 - 227
12345